LUMIGEN, INC.

Company Information

Company Name
LUMIGEN, INC.
Address
LUMIGEN, INC.
22900 W EIGHT MILE RD
SOUTHFIELD, MI, 48034 0430
Phone
1 248-351-5600
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$545,696.00
7
SBIR Phase II
$2,218,520.00
3
Chart code to be here

Award List

  1. Ultrasensitive Chemiluminescent Enzyme-Linked Assays

    Amount: $749,680.00

    Our objective is to prove feasibility of ultrasensitive chemiluminescent assays for the 21 aminoacid polypeptide from HIV gp 120 by Western blotting and cystic fibrosis transmembrane regulator geneby ...

    SBIR Phase II 1995 Department of Health and Human Services
  2. NOVEL CHEMILUMINESCENT DETECTION OF GENE REARRANGEMENTS

    Amount: $100,000.00

    The objective of Phase I is to develop simple, sensitive and unambiguous chemiluminescent detection of juxtaposed genes in chromosomal translocations associated with many cancers. We propose chemilum ...

    SBIR Phase I 1997 Department of Health and Human Services
  3. Molecular Diagnostic Assays for Genetic Disease

    Amount: $96,178.00

    DESCRIPTION (Applicant's Abstract): The objective of Phase 1 is to develop a sensitive test and kit for detection of the Factor V Leiden mutation in human blood using a new nucleic acid ...

    SBIR Phase I 2001 Department of Health and Human Services
  4. CHEMILUMINESCENT LABELING AND DETECTION IN GELS

    Amount: $100,000.00

    The objective of Phase I is to prepare a new family of chemiluminescent label compounds which can be conjugated to proteins and nucleic acids, subjected to electrophoresis and triggered to generate ch ...

    SBIR Phase I 2002 Department of Health and Human Services
  5. Molecular Diagnostic Assays for Genetic Diseases

    Amount: $0.00

    DESCRIPTION (provided by applicant): Phase I of this proposal proved the feasibility of detection of the factor V Leiden mutation in human blood and correct determination of sample genotype as compare ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Molecular Diagnostic Assays for Genetic Diseases

    Amount: $737,428.00

    DESCRIPTION (provided by applicant): Phase I of this proposal proved the feasibility of detection of the factor V Leiden mutation in human blood and correct determination of sample genotype as compare ...

    SBIR Phase II 2003 Department of Health and Human Services
  7. Materials for Isolation of Nucleic Acids from Whole Blood without a Lysis Step

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The objective of the proposed study is to develop new materials for the rapid isolation of nucleic acids from complex matrices such as whole blood. In Phase I w ...

    SBIR Phase I 2005 Department of Health and Human Services
  8. Materials for Isolation of Nucleic Acids from Whole Blood without a Lysis Step

    Amount: $731,412.00

    DESCRIPTION (provided by applicant): This Phase II project continues the development and application of new materials, especially magnetic microparticles for directly isolating DNA from cells, tissues ...

    SBIR Phase II 2006 Department of Health and Human Services
  9. MULTIPLEX CHEMILUMINESCENT DNA SEQUENCING

    Amount: $75,017.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  10. Ultrasensitive Chemiluminescent Enzyme-Linked Assays

    Amount: $74,501.00

    N/A

    SBIR Phase I 1994 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government